In Phase A, participants will acquire diverse doses and schedules of oral ABBV-744 pill to determine Safe and sound dosing regimen. Further contributors will likely be enrolled for the discovered monotherapy dosign regimen. In Segment B, individuals will get oral ruxolitinib and ABBV-744 will be provided as "insert-on" therapy. In https://aleisterz110juf2.losblogos.com/profile